- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02024698
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
July 19, 2020 updated by: CooperVision, Inc.
The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.
Study Overview
Detailed Description
The purpose of this cross-over study is to evaluate the clinical performance of the ProClear-1 Day in comparison with 1-Day Acuvue® Moist®.
In particular, the study will focus on lens wearing comfort.
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85032
- Phoenix Eye Care, PLLC
-
-
Illinois
-
Lake Zurich, Illinois, United States, 60047
- Lake Zurich Eye Care
-
-
Ohio
-
Athens, Ohio, United States, 45701
- Drs. Quinn, Foster & Assoc.
-
New Albany, Ohio, United States, 43054
- Vision Professionals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
- Is between 18 and 40 years of age (inclusive)
- Have the use of a mobile phone to send and receive text messages throughout the day for the duration of the study.
- Has had a self-reported visual exam in the last two years
- Is an adapted soft CL (Contact Lens) wearer
- Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per day, assuming there are no contraindications for doing so
- Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)
- Has less than 0.75D (Diopters) spectacle cylinder in each eye.
- Is correctable to a visual acuity of 20/25 or better in both eyes
- Has clear corneas and no active ocular disease
- Has read, understood and signed the information consent letter.
- Is willing to comply with the wear schedule (at least 40 hrs per week)
- Is willing to comply with the visit schedule
Exclusion Criteria:
A person will be excluded from the study if he/she:
- Has never worn contact lenses before.
- Currently wears rigid gas permeable contact lenses.
- Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
- Has a CL prescription outside the range of - 1.00 to -6.00D
- Has a spectacle cylinder greater than -0.50D of cylinder in either eye.
- Has best corrected spectacle distance vision worse then 20/25 in either eye.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications that will affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion
- Has persistent, clinically significant corneal or conjunctival staining
- Has active neovascularization or any central corneal scars.
- Is aphakic.
- Is presbyopic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: omafilcon A
Study participants are randomized to wear omafilcon A lenses.
|
contact lens
Other Names:
|
|
Active Comparator: etafilcon A
Study participants are randomized to wear etafilcon A lenses.
|
contact lens
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort (Subjective Assessment)
Time Frame: Baseline
|
Subjective Assessment of comfort on insertion at baseline for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very uncomfortable, 10=cannot feel)
|
Baseline
|
|
Comfort (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Insertion Comfort, Comfort During Day, Comfort Prior to Removal, Comfort Overall for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very uncomfortable, 10=cannot feel)
|
1 Week
|
|
Hydration (Subjective Assessment)
Time Frame: Baseline
|
Subjective Assessment of hydration on insertion at baseline for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very dehydrated, not hydrophilic, very dry, 10=very hydrated, ultra hydrophilic)
|
Baseline
|
|
Hydration (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Initial Hydration, Hydration During Day, Hydration Prior to Removal for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very dehydrated, not hydrophilic, very dry, 10=very hydrated, ultra hydrophilic)
|
1 Week
|
|
Vision Quality (Subjective Assessment)
Time Frame: Baseline
|
Subjective Assessment: Visual quality on insertion at baseline for each pair using questionnaire and rated on subjective response scale (0-10; 0= clear vision, 10=perfectly sharp)
|
Baseline
|
|
Vision Satisfaction (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Vision Satisfaction for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very unsatisfied, 10=very satisfied)
|
1 Week
|
|
Dryness (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Dryness During Day, Dryness Prior to Removal, Overall Dryness for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very dry, 10=no dryness)
|
1 Week
|
|
Handling (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Handling on Insertion and Removal, Overall Handling for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= very difficult, 10=very easy)
|
1 Week
|
|
Eye Whiteness/Redness (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Eye Whiteness/Redness for each pair using questionnaire and rated on subjective response scale.
(0-10; 0= significant redness, 10=totally white)
|
1 Week
|
|
Overall Sensation of Smoothness (Subjective Assessment)
Time Frame: 1 Week
|
Subjective Assessment: Overall sensation of smoothness at 1 week wear for each pair when asked "How would you rate the overall sensation of smoothness (deposit resistance) of the first study lenses, over the last week of wear?" (Likert 1-5; 1=excellent, 2=good, 3=average, 4=below average, 5=poor)
|
1 Week
|
|
Overall Satisfaction for Lens
Time Frame: 1 Week
|
Subjective Assessment: Satisfaction overall at 1 Week wear for each pair when asked "Overall, how satisfied was the subject with the study lenses, during the last week, with regards to: Overall?" (Likert 1-4; 1=completely satisfied, 2=somewhat satisfied, 3=somewhat dissatisfied, 4=completely dissatisfied)
|
1 Week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Donald Siegel, OD, Sun City West Eye Care
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
December 27, 2013
First Submitted That Met QC Criteria
December 27, 2013
First Posted (Estimate)
December 31, 2013
Study Record Updates
Last Update Posted (Actual)
July 30, 2020
Last Update Submitted That Met QC Criteria
July 19, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-43
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
-
Universidad Complutense de MadridCooperativa de Ensino Superior, Politécnico e Universitário; Novovision; Instituto... and other collaboratorsActive, not recruiting
Clinical Trials on etafilcon A
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Eurolens ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.; Johnson & Johnson K.K. Medical CompanyCompleted